References | Country | Study design | Study population | Recruiting time | Uptake time (min) | Lymphade-nectomy | Age Median (range) Median (IQRe) | PSAd median (range) Median (IQR) | Patient characteristics |
---|---|---|---|---|---|---|---|---|---|
Budaus [25] | Germany | Retrospective | Single center | June. 2014 to Mar. 2015 | NA | ePLNDf | 63 (44–75) | 8.8 (1.4–376) | High risk |
Herlemann [20] | Germany | Retrospective | Single center | Jan. 2014 to Aug. 2015 | 60 | PLNDg | 70.5 (59–80)b | 56 (3.3–36.3)b | 4 intermediate risk and 16 high risk |
Maurer [24] | Germany | Retrospective | Single center | Dec. 2012 to Nov. 2014 | 59.8 ± 17.8a | PLND | 66 (45–84) | 11.6 (0.57–244) | 42 intermediate risk and 88 high risk |
Gupta [22] | India | Retrospective | Single center | Dec. 2014 to Dec. 2015 | Nearly 60 | ePLND | NA | NA | High risk |
Obek [21] | Turkey | Retrospective | Single center | July. 2014 to Oct. 2015 | 45–60 | ePLND | 64 ± 6.0a | 26.5 ± 21.4a | 44 high risk and 7 very high risk |
Van Leeuwen [26] | Australia | Prospective | Single center | Apr. to Oct. 2015 | 60 | ePLND | 65 (60–71) | 65 (55–82) | 3 intermediate risk and 27 high risk |
Zhang [12] | China | Retrospective | Single center | Mar. to July. 2017 | 60 | PLND | 69 (55–82) | 37.25 (7.2–348) | 17 intermediate risk and 25 high risk |
Van Leeuwen [2] | Australia | Retrospective | Single center | Feb. 2015 to Oct. 2017 | 60 | ePLND | NA | 9.4 | 140 intermediate risk and high risk |
Yilmaz [23] | Turkey | Retrospective | Single center | May. 2016 to Apr. 2018 | Approximately 60 | rLNDc | 62.8 (49–73)b | 12 (2.4–32)b | 15 intermediate risk and 6 high risk |
Yaxley [13] | Australia | Retrospective | Single center | July. 2014 to Sep. 2017 | 45–60 | PLND | 68 (44–80) | 7.6 (1.5–51) | 85 intermediate risk and 123 high risk |